Prefrontal norepinephrine determines attribution of "high" motivational salience.

PloS One
Rossella VenturaStefano Puglisi-Allegra

Abstract

Intense motivational salience attribution is considered to have a major role in the development of different psychopathologies. Numerous brain areas are involved in "normal" motivational salience attribution processes; however, it is not clear whether common or different neural mechanisms also underlie intense motivational salience attribution. To elucidate this a brain area and a neural system had to be envisaged that were involved only in motivational salience attribution to highly salient stimuli. Using intracerebral microdialysis, we found that natural stimuli induced an increase in norepinephrine release in the medial prefrontal cortex of mice proportional to their salience, and that selective prefrontal norepinephrine depletion abolished the increase of norepinephrine release in the medial prefrontal cortex induced by exposure to appetitive (palatable food) or aversive (light) stimuli independently of salience. However, selective norepinephrine depletion in the medial prefrontal cortex impaired the place conditioning induced exclusively by highly salient stimuli, thus indicating that prefrontal noradrenergic transmission determines approach or avoidance responses to both reward- and aversion-related natural stimuli only w...Continue Reading

References

May 30, 1998·Journal of Neuroscience Methods·T SaitoT Nemoto
Dec 22, 1998·Brain Research. Brain Research Reviews·K C Berridge, T E Robinson
Nov 24, 1999·Biological Psychiatry·G Aston-JonesJ Cohen
Jul 21, 2000·Biological Psychiatry·S Grossberg
Jan 3, 2001·Nature Neuroscience·J O'DohertyC Andrews
Apr 17, 2001·The Behavioral and Brain Sciences·E T Rolls
May 30, 2002·Neuroscience and Biobehavioral Reviews·Rudolf N CardinalBarry J Everitt
Sep 2, 2003·NeuroImage·William D S KillgoreDeborah A Yurgelun-Todd
Sep 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rossella VenturaStefano Puglisi-Allegra
Sep 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mary F DallmanSotara Manalo
Feb 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Benno RoozendaalJames L McGaugh
Mar 12, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Susana MingoteMatthijs G P Feenstra
Mar 31, 2004·NeuroImage·Gene-Jack WangJoanna S Fowler
Oct 7, 2004·Neuropharmacology·Gaetano Di ChiaraDaniele Lecca
Aug 2, 2005·The American Journal of Psychiatry·Peter W Kalivas, Nora D Volkow
Jan 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Adam K AndersonJohn D E Gabrieli
Feb 24, 2006·European Journal of Pain : EJP·David BorsookJon Levine
Mar 21, 2006·Trends in Neurosciences·Bernard W Balleine, Simon Killcross
Jun 24, 2006·Trends in Cognitive Sciences·James L McGaugh
Oct 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Gene-Jack WangJoanna S Fowler
Jan 11, 2007·Neuroscience and Biobehavioral Reviews·C Martin-SoelchM Ernst
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Rossella VenturaStefano Puglisi-Allegra

❮ Previous
Next ❯

Citations

Jan 1, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Poppy L A SchoenbergAnne E M Speckens
Feb 10, 2010·BMC Neuroscience·Emanuele Claudio LatagliataRossella Ventura
Oct 12, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Martin ZackUsoa E Busto
Mar 6, 2012·Applied Neuropsychology. Adult·Theodore Wasserman
Oct 24, 2014·Nutrients·Matteo Di SegniRossella Ventura
Aug 28, 2012·Pharmacology, Biochemistry, and Behavior·Torry S DennisLinda I Perrotti
Jul 16, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E J Marijke AchterbergLouk J M J Vanderschuren
Oct 8, 2011·Neurotoxicology and Teratology·V B ThompsonJ W Lipton
Mar 15, 2011·Behavioural Brain Research·Davide AmatoChristian P Müller
Nov 26, 2009·Behavioural Brain Research·Devin Mueller, Shawn P Cahill
Dec 15, 2015·Psychopharmacology·Emanuele Claudio LatagliataStefano Puglisi-Allegra
Apr 8, 2015·Pharmacology, Biochemistry, and Behavior·Anahita Torkaman-BoutorabiMohammad-Reza Zarrindast
Dec 15, 2010·Neuron·Ethan S Bromberg-MartinOkihide Hikosaka
Feb 24, 2015·Frontiers in Systems Neuroscience·Diego AndolinaRossella Ventura
Aug 8, 2014·Frontiers in Psychiatry·Marijn LijffijtAlan C Swann
Mar 18, 2015·PloS One·Enrico PatronoRossella Ventura
Jul 11, 2014·Neuroscience and Biobehavioral Reviews·Dave J HayesGeorg Northoff
Dec 31, 2016·Brain and Cognition·Ryan S WilliamsJulia Spaniol
Jul 25, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Renata S CouraSylvie Granon
Mar 30, 2018·Frontiers in Behavioral Neuroscience·Thomas F Giustino, Stephen Maren
Jul 13, 2018·Psychopharmacology·Caroline I JahnSebastien Bouret
Oct 31, 2017·Brain Structure & Function·Valeria OlivaGianluca Baldassarre
Aug 30, 2017·Frontiers in Pharmacology·Emanuele C LatagliataStefano Puglisi-Allegra
Oct 13, 2020·PLoS Biology·Nicolas BorderiesSebastien Bouret
Jul 17, 2018·Neuropharmacology·Caitlin A OrsiniBarry Setlow
Nov 13, 2017·Behavioural Brain Research·Kyle Z PasquarielloPaul J Meyer
Aug 17, 2021·Psychological Research·Yudai Takarada, Daichi Nozaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.